Officials examine deaths after plasma donations in Winnipeg
medicalxpress - Canadian health officials are investigating the deaths of two people who donated plasma at private clinics in Winnipeg, Manitoba.
AI Summary: Health officials are investigating the deaths of two people who recently donated plasma at for‑profit clinics in Winnipeg, prompting scrutiny of donation frequency, screening practices and clinic oversight. Regulators are reviewing protocols and collecting evidence as public health teams work to determine whether systemic safety failures or procedural lapses contributed to the fatalities.
Trial finds vitamin D supplements don't reduce COVID severity but could reduce long COVID risk
medicalxpress - In a large, randomized trial, researchers at Mass General Brigham found that high-dose vitamin D3 did not reduce COVID-19 infection severity, but may impact long COVID outcomes. Results of the study are published in The Journal of Nutrition.
AI Summary: A large randomized trial found high‑dose vitamin D3 did not lower acute COVID‑19 severity but revealed a surprising signal: supplementation may reduce the risk of developing long‑COVID. The result complicates the vitamin D narrative — not a cure, perhaps a modest shield against persistent post‑infectious symptoms worthy of further investigation.
FDA Drug Approval Marks a First for a Disease — But It’s Not Autism
Frank Vinluan / medcitynews - Leucovorin is now approved for cerebral folate deficiency months after FDA Commissioner Marty Makary claimed the decades-old generic drug had promise for treating autism. The FDA’s review was based on published literature and real-world evidence.The post …
AI Summary: The FDA has granted traditional approval to leucovorin for cerebral folate deficiency, formalizing a decades‑old generic’s role in a rare metabolic disorder. The decision comes amid earlier agency notes that evidence for autism benefit was weak and debate over expanding use without fresh trial data — cue the policy hot takes.
Fitch upgrades UCHealth’s rating to ‘AA+’
Andrew Cass / beckershospitalreview - Aurora, Colo.-based UCHealth’s credit rating was upgraded to “AA+” from “AA” by Fitch. The upgrade reflects the health system’s very strong financial profile, benefiting from its market position in a growing service area and a long track record of robust …
AI Summary: A large NHS evaluation found that an AI system can detect more invasive breast cancers than traditional reading alone, boosting detection by roughly 10%. The technology matched or rivaled radiologists in a major screening dataset, prompting debate about integration, workflow changes, and careful real-world rollout rather than unleashing bots in mammography rooms immediately.
- Mixed trial findings: AI triage not always noninferior. (1)
- NHS trial: AI boosts breast cancer detection by ~10%. (2)
- OTHER: AI in broader cardiac, hematology, imaging, and finance news. (4)
- Researchers and conferences push AI discussion in breast imaging. (2)
- All Other Stories
Mixed trial findings: AI triage not always noninferior.
NHS trial: AI boosts breast cancer detection by ~10%.
OTHER: AI in broader cardiac, hematology, imaging, and finance news.
Researchers and conferences push AI discussion in breast imaging.
All Other Stories
Personalized Support Program Improves Smoking Cessation for Cervical Cancer Survivors – UCLA Health
oncodaily - UCLA study shows program doubles quit rates for women and offers a cost-effective approach A new study led by UCLA researchers suggests that a personalized counseling program can significantly help […]
AI Summary: A UCLA-led trial found that a tailored support program for women treated for cervical precancer significantly doubled smoking-cessation rates versus usual care. The intervention combined individualized counseling, follow-up, and survivor-focused resources, proving both clinically impactful and cost-effective — because apparently telling people to “just quit” still isn’t working.
Measles outbreaks could fuel rise in fatal complication, physicians warn
Mackenzie Bean / beckershospitalreview - As measles continues spreading across the U.S. at a pace not seen in decades, physicians are warning about a rare but often fatal neurological complication that can emerge years after initial infection, KFF Health News reported March 13. Subacute sclerosi…
AI Summary: Measles is resurging across the United States at levels not seen in decades, and clinicians warn this spike could drive an increase in a rare but often fatal neurological complication. Public‑health experts point to falling vaccination coverage and gaps in outbreak control as the drivers, urging renewed immunization efforts and vigilance.
AMA: Physicians' use of AI doubled from 2023 to 2026
fiercehealthcare - A survey fielded earlier this year found 81% of doctors use AI in a professional context, with an average of 2.3 use cases per physician. Respondents were largely bullish on the technology's ability to boost clinical care and work efficiency, but still ha…
AI Summary: An AMA survey finds physicians’ professional use of artificial intelligence roughly doubled from 2023 to 2026, with about 81% of doctors now using AI across clinical and administrative tasks. The rapid uptake spotlights workflow integration but raises immediate questions about oversight, training, and legal liability as adoption outpaces policy.
Eliquis may be safer than Xarelto for patients with deep blood clots: Study
Ella Jeffries / beckershospitalreview - Patients taking blood thinner Eliquis had a lower risk of clinically relevant bleeding than those taking Xarelto, a recent study found. Researchers enrolled 2,760 patients with venous thrombosis — blood clots in the veins of the legs or lungs — and random…
AI Summary: A direct comparison trial found apixaban (Eliquis) produced a lower rate of clinically relevant bleeding than rivaroxaban (Xarelto) in patients treated for venous thromboembolism while preserving efficacy against clots. The results offer prescribers clear comparative safety data that could influence anticoagulant selection and guideline recommendations.
Flu vaccines didn't work that well in the US, officials find
medicalxpress - As the U.S. flu season winds down, health officials say the flu vaccine didn't work very well, with one of its worst effectiveness rates in more than a decade.
AI Summary: Health officials report this season’s influenza vaccine performed poorly, with effectiveness among the lowest in recent years. A mismatch between vaccine strains and circulating viruses reduced protection, prompting calls for strain updates ahead of the fall program. Public health leaders still urge vaccination for partial protection and to blunt severe outcomes.
A smartphone app can help men last longer in bed
newscientist - In a randomised trial, men who experience premature ejaculation benefitted from using an app to learn techniques for extending intercourse
AI Summary: A randomized trial shows a smartphone app teaching behavioral and psychological techniques significantly prolonged intercourse and improved sexual satisfaction for men with premature ejaculation. The digital program provided a non‑pharmacologic, scalable alternative to pills, offering clinicians an accessible adjunct or first‑line option for patients keen to try therapy without a prescription.
Severe COVID or Severe Flu May Raise Risk of Lung Cancer, But Vaccines Helped in Animal Tests
discovermagazine - Learn how severe respiratory illness leaves the lungs vulnerable to cancer, and how vaccines could prevent these vulnerabilities.
AI Summary: New animal and observational evidence suggests severe respiratory infections—including serious COVID‑19 and influenza—can prime lung tissue and accelerate cancer development months to years later. Vaccination appeared to blunt those effects in experimental models, highlighting prevention as a potential cancer‑risk reduction strategy and urging clinicians to watch survivors of severe infections more closely.
6 Things to Know About Stryker’s Cyberattack
Katie Adams / medcitynews - Stryker was hit by a cyberattack this week that knocked out its internal systems worldwide and caused delays to order processing and manufacturing. An Iran-linked group has claimed responsibility for the attack, but the full impact remains unclear.The pos…
AI Summary: A worldwide cyberattack knocked out Stryker’s enterprise Microsoft environment, wiping access to key internal systems and forcing hospitals and manufacturers to scramble for workarounds. The company is issuing platform‑specific updates while investigators link the intrusion to a pro‑Iran actor, leaving supply chains and surgical workflows nervously improvising.
FDA Transparency Push Expands to Monitoring Safety of Vaccines and Other Regulated Products
Frank Vinluan / medcitynews - The FDA said consolidating safety reporting into a single platform, the Adverse Event Monitoring System (AEMS), will increase transparency and reduce costs. But like the legacy systems it replaces, AEMS reports are unverified so causation and frequency of…
AI Summary: The FDA is consolidating multiple safety reporting systems into a single public Adverse Event Monitoring System to centralize reports for drugs, biologics, vaccines, cosmetics and animal products. The move aims to improve transparency, reduce fragmented reporting, and streamline monitoring — a tidy solution if it works as promised.
Gallup poll: One in three Americans cutting back on daily expenses to pay for healthcare
fiercehealthcare - Healthcare affordability remains a significant challenge, with a third of respondents to a new Gallup poll saying they had to cut back on daily living expenses to afford care.
AI Summary: A Gallup poll reports one-third of Americans trimmed everyday spending, borrowed money or skipped essentials to pay medical bills. The findings highlight acute affordability pressures that force families to choose between care and basic needs, underscoring systemic gaps in coverage and cost control while policymakers offer the usual sympathetic nod.
Leapfrog ordered to remove safety grade for 5 Tenet hospitals
fiercehealthcare - A federal judge said a 2024 methodology update that adjusted the weighting of safety measures inputted for nonparticipating hospitals was "deceptive and unfair" under Florida law. Leapfrog plans to appeal, but said it will be making broader changes in rat…
AI Summary: A federal judge ruled that Leapfrog’s safety grades for five Florida hospitals—primarily Tenet-owned facilities—were based on a methodology the court deemed scientifically unsupported and potentially deceptive. The decision requires Leapfrog to take down those grades, raising fresh questions about the design, transparency and legal defensibility of high-profile hospital safety metrics.
Effects of daily multivitamin–multimineral and cocoa extract supplementation on epigenetic aging clocks in the COSMOS randomized clinical trial
Sidong Li / nature - Nature Medicine, Published online: 09 March 2026; doi:10.1038/s41591-026-04239-3In a prespecified ancillary analysis of the COSMOS randomized trial, supplementation with daily multivitamins, but not with cocoa extract, over the course of 2 years decreased…
AI Summary: A prespecified ancillary analysis of the COSMOS randomized trial found that daily multivitamin–multimineral (with cocoa extract) modestly slowed epigenetic aging clocks over two years. The Nature Medicine report highlights measurable shifts in biomarkers of biological aging, while noting uncertain clinical significance and the need for longer follow-up.
White House autism briefing linked to swift shifts in prescribing patterns
medicalxpress - A White House briefing in September 2025 that raised concerns about acetaminophen use during pregnancy and promoted the drug leucovorin as a potential autism treatment was followed by sharp changes in how doctors prescribed those medications nationwide, a…
AI Summary: A White House briefing warning about acetaminophen in pregnancy and promoting alternate therapies led to an immediate, measurable decline in ER acetaminophen orders for pregnant patients. The episode shows how high‑profile public messaging can swiftly reshape clinical behavior — for better or worse — and raises questions about evidence, communication and unintended consequences.
Patients with multiple chronic diseases are a looming threat to health systems' financials: Vizient
fiercehealthcare - A recent claims data analysis shows the 11% of people with multiple chronic conditions are behind 52% of inpatient admissions and about a third of outpatient visits. Their projected increases and unfavorable payer mix spell trouble for health systems' bot…
AI Summary: A Vizient analysis shows roughly 11% of the U.S. population accounts for about 52% of hospital admissions, spotlighting how patients with multiple chronic conditions consume disproportionate inpatient resources. The report warns this concentration strains hospital finances and operational capacity, and calls for targeted care models to manage high‑need populations more efficiently.
How springing forward to daylight saving time could affect your health
medicalxpress - Most of America "springs forward" Sunday for daylight saving time. Losing that hour of sleep can do more than leave you tired and cranky the next day; it also could harm your health.
AI Summary: The clock change that robs people of an hour of sleep is back, and so are the predictable health hiccups: disrupted circadian rhythm, deeper sleep loss and more migraine flare‑ups. Experts warn even a single lost hour can nudge vulnerable people toward worse sleep, mood and short‑term cardiovascular risk — so yes, your crankiness is data‑backed.
CART19-BE-02 trial: From Bench to Bedside and Beyond – Resonance
oncodaily - ALRCaN presents “CART19-BE-02 trial: From Bench to Bedside and Beyond—Implementing a Hospital-Based CAR T Program and Integrating It into the Spanish NHS” with Dr. Valentín Ortiz-Maldonado. “Dear friends and colleagues, […]
AI Summary: Bereaved relatives delivered searing final testimonies as the Covid inquiry wound up four years of public hearings, recounting loved ones who died alone and demanding answers. Chair Baroness Heather Hallett defended the process and its roughly £200 million price tag as necessary to finish the work, despite public frustration and political scrutiny.